Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib

F. Takahashi, N. Chiba, K. Tajima, T. Hayashida, T. Shimada, M. Takahashi, H. Moriyama, E. Brachtel, E. J. Edelman, S. Ramaswamy, S. Maheswaran

Research output: Contribution to journalArticlepeer-review

45 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences